Therapeutic High Affinity T Cell Receptor Targeting a KRAS^G12D Cancer Neoantigen

The authors showed the identification and development of an affinity-enhanced T cell receptor that recognized a peptide derived from the most common KRAS mutant, KRASG12D, presented in the context of HLA-A*11:01.